Bridging Australian biotech with European capital, partners, funding, and market access under the new AU–EU Free Trade Agreement

What we help with

Go-To-Market

Define market entry and validate demand through segmentation, positioning, pricing, and early traction development

Capital Readiness & Funding

Prepare for institutional capital with financial planning, investor positioning, capital strategy, and EU funding access

EU Partner Search & Commercial Execution

Distributor and strategic partner search, regulatory navigation, and fractional CRO execution embedded in Europe

Accessing European Capital Pools

16x

Europe is 16x larger than Australia

in biotech capital raised

AUSTRALIA

$829M

biotech raised 2025

EUROPE

$13.4B

biotech raised 2025

Horizon Europe Funding Programme (2021–2027) — world's largest R&D programme, now open to AU biotech under the FTA

€95B

EU funding pools — now open to AU biotech

  1. EIC Accelerator
    up to €17.5M per company (grant + equity)

  2. Horizon Europe Health
    collaborative R&D, EU consortia

  3. EIB venture debt
    biotech scale-up financing

  4. Member-State grants
    Germany ZIM, France 2030, UK Innovate

What IDB helps you do

✓ Capital Readiness Sprint
investor deck, financial model, EU data room

✓ EU partner network
distributor & strategic partner search (Frankfurt-based)

✓ EU regulatory navigation
EMA, GMP, market access, reimbursement

✓ On-ground commercial execution
Fractional CRO embedded in EU